Encompass Health Corporation
EHC
$112.67
$0.670.60%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 541.00M | 522.70M | 494.70M | 455.70M | 422.40M |
| Total Depreciation and Amortization | 319.50M | 315.50M | 308.50M | 299.60M | 291.70M |
| Total Amortization of Deferred Charges | 9.70M | 9.70M | 9.70M | 9.70M | 9.50M |
| Total Other Non-Cash Items | 245.00M | 233.60M | 223.70M | 215.90M | 190.90M |
| Change in Net Operating Assets | -6.80M | 23.90M | 16.00M | 21.90M | 10.50M |
| Cash from Operations | 1.11B | 1.11B | 1.05B | 1.00B | 925.00M |
| Capital Expenditure | -705.80M | -666.20M | -666.20M | -642.50M | -655.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.10M | -22.90M | -15.90M | -10.80M | -2.20M |
| Cash from Investing | -728.90M | -689.10M | -682.10M | -653.30M | -657.70M |
| Total Debt Issued | 170.00M | 105.00M | 105.00M | 95.00M | 65.00M |
| Total Debt Repaid | -328.30M | -376.20M | -367.00M | -337.00M | -225.70M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -109.10M | -91.00M | -83.00M | -43.20M | -35.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -69.10M | -67.10M | -64.90M | -62.80M | -60.70M |
| Other Financing Activities | -148.20M | -31.70M | -10.50M | 17.40M | 47.60M |
| Cash from Financing | -484.70M | -461.00M | -420.40M | -330.60M | -209.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.20M | -44.70M | -49.90M | 18.90M | 57.70M |